title: -to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110.
authors.forename: M
authors.initials: M
authors.lastname: Rotondi
authors.forename: P
authors.initials: P
authors.lastname: Romagnani
authors.forename: A
authors.initials: A
authors.lastname: Brozzetti
authors.forename: F
authors.initials: F
authors.lastname: Santeusanio
authors.forename: M
authors.initials: M
authors.lastname: Serio
authors.forename: A
authors.initials: A
authors.lastname: Falorni
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D054357:Chemokine CXCL10; D019743:Chemokines, CXC / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D007371:Interferon-gamma / Q000097:blood / Q000494:pharmacology
chemical_list: D001323:Autoantibodies; D054357:Chemokine CXCL10; D019743:Chemokines, CXC; C024211:islet cell antibody; D007371:Interferon-gamma